Utkan Demirci,
Professor,
Stanford University School of Medicine
Utkan Demirci, PhD, is a professor with tenure at Stanford University School of Medicine at the Canary Center at Stanford for Cancer Early Detection. Before moving to Stanford, he was an associate professor of Medicine and Health Sciences and Technology at Brigham and Women’s Hospital, Harvard Medical School (HMS) and Harvard- Massachusetts Institute of Technology (MIT) Health Sciences and Technology. His group is focused on the development of point-of-care technologies and creating microfluidic platforms for sorting rare cells and exosomes for infectious diseases and cancer. His early work founded the basics of 3-D bioprinting of cells and biomaterials.
Portable Platform Technologies for Detecting Pathogens and Cells at the Point-of-Care
Tuesday, 29 September 2015 at 17:30
Add to Calendar ▼2015-09-29 17:30:002015-09-29 18:30:00Europe/LondonPortable Platform Technologies for Detecting Pathogens and Cells at the Point-of-CarePoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Micro/nano-scale technologies can have a significant impact on medicine and biology in the areas of cell manipulation, diagnostics and monitoring. At the convergence of these new technologies and biology, we research for enabling solutions to the real world problems at the clinic. Emerging nano-scale and microfluidic technologies integrated with biology offer innovative possibilities for creating intelligent, mobile medical lab-chip devices that could transform diagnostics and monitoring, tissue engineering and regenerative medicine. In this talk, we will present an overview of our laboratory's work in these areas focused on applications in point-of-care and primary care settings including applications for ovarian cancer detection from urine, rapid CD4 counts for global health, multiple pathogen detection with a focus on viral load from unprocessed whole blood and bedside peritonitis detection for end-stage kidney disease patients going through peritoneal dialysis therapy. These emerging technologies could shape our future creating broadly applicable platforms for scientific discovery, providing clinical solutions for resource-constrained settings in the developing world as well as for primary care settings in the developed world.
Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health World CongressPoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2015-09-29 17:30:002015-09-29 18:30:00Europe/LondonPortable Platform Technologies for Detecting Pathogens and Cells at the Point-of-CarePoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
